Abstract
AbstractThe increasing chronicity and multimorbidities associated with people living with HIV have posed important challenges to health systems across the world. In this context, payment models hold the potential to improve care across a spectrum of clinical conditions. This study aims to systematically review the evidence of HIV performance-based payments models. Literature searches were conducted in March 2020 using multiple databases and manual searches of relevant papers. Papers were limited to any study design that considers the real-world utilisation of performance-based payment models applied to the HIV domain. A total of 23 full-text papers were included. Due to the heterogeneity of study designs, the multiple types of interventions and its implementation across distinct areas of HIV care, direct comparisons between studies were deemed unsuitable. Most evidence focused on healthcare users (83%), seeking to directly affect patients' behaviour based on principles of behavioural economics. Despite the variability between interventions, the implementation of performance-based payment models led to either a neutral or positive impact throughout the HIV care continuum. Moreover, this improvement was likely to be cost-effective or, at least, did not compromise the healthcare system’s financial sustainability. However, more research is needed to assess the durability of incentives and its appropriate relative magnitude.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology
Reference42 articles.
1. Oliva-Moreno J, Trapero-Bertran M. Economic Impact of HIV in the Highly Active Antiretroviral Therapy Era - Reflections Looking Forward. AIDS Rev. 2018;20(4):226–35. https://doi.org/10.24875/AIDSRev.M17000011.
2. Struckmann V, Quentin W, Busse R, van Ginneken E. How to strengthen financing mechanisms to promote care for people with multimorbidity in Europe? Copenhagen (Denmark): European Observatory on Health Systems and Policies, 2017.
3. Johnson C et al., Systematic review of HIV testing costs in high and low income settings. World Health Organization, 2015. Accessed: Sep. 07, 2020. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK316032/.
4. Srivastava S, Singh PK, Vatsalya V, Karch RC. Developments in the diagnostic techniques of infectious diseases: rural and urban prospective. Adv Infect Dis. 2018. https://doi.org/10.4236/aid.2018.83012.
5. Costa C, Santana R, Boto P. “Financiamento por capitação ajustada pelo risco : conceptualização e aplicação,” Rev. Port. Saúde Pública, Temático 7, 67–102, 2008.